Major Pharmaceuticals midodrine tablets recalled for packaging defect
Major Pharmaceuticals is recalling midodrine hydrochloride 5 mg tablets (Lot N02640, expiring 08/2027) because some blister packages are not properly sealed. Defective packaging could allow the medication to degrade or become contaminated. No injuries have been reported.
From the FDA notice · Read the official notice ↗ · All The Harvard Drug recalls
What to do
- Check if you have midodrine tablets from Lot N02640 with expiration date 08/2027
- Inspect the blister packaging for signs of damage or incomplete sealing
- Contact your pharmacist or doctor if you have this lot; do not use if packaging appears defective
- Do not dispose of medication in household trash; ask your pharmacy about safe disposal
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-6818-06.
- Sold in
- Nationwide
- Made for
- Adults (0 months and older)
Details
- Units affected
- 8892 cartons
- Illnesses reported
- None reported
- Manufactured in
- 7000 Cardinal Pl, N/A, Dublin, OH, United States
- Classification
- Class II
- Recall number
- D-0383-2026
In the FDA's words
- Description
- Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-6818-06. Defective container; inadequately sealed blister packaging. Lot # N02640, Exp Date: 08/2027 Distribution: Nationwide US. Affected quantity: 8892 cartons
- Hazard
- Defective container; inadequately sealed blister packaging.